Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 31

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Eastern Cooperative Oncology Group

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Erica Campagnaro

Case Comprehensive Cancer Center

Moderately Similar
1 trials

Shared therapeutic areas:

Stage I Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Ann Mohrbacher, MD

University of Southern California

Moderately Similar
4 trials

Shared therapeutic areas:

Stage I Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Craig Hofmeister, MD

Ohio State University

Moderately Similar
4 trials

Shared therapeutic areas:

Stage I Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma
Similarity Score30%

Zaid Al-Kadhimi

Barbara Ann Karmanos Cancer Institute

Moderately Similar
1 trials

Shared therapeutic areas:

Stage I Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Alexander Stewart

Mayo Clinic

Moderately Similar
1 trials

Shared therapeutic areas:

Stage I Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Angela Dispenzieri

Mayo Clinic

Moderately Similar
3 trials

Shared therapeutic areas:

Stage I Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Ryotaro Nakamura

City of Hope Medical Center

Moderately Similar
10 trials

Shared therapeutic areas:

Stage I Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Mohamad A. Hussein, MD

The Cleveland Clinic

Moderately Similar
8 trials

Shared therapeutic areas:

Stage I Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Shaji Kumar, M.D.

Mayo Clinic

Moderately Similar
7 trials

Shared therapeutic areas:

Stage I Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Vinod Pullarkat, MD

City of Hope Medical Center

Moderately Similar
1 trials

Shared therapeutic areas:

Stage I Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT00002556Phase 3PrincipalInvestigator

Combination Chemotherapy With or Without High Dose Cyclophosphamide and Recombinant Interferon Alfa-2b in Treating Patients With Previously Untreated Stage I-III Multiple Myeloma

Stage I Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma
Completed

All 1 trials loaded